About Xuezhikang lipid therapy on different time.docVIP

 PAGE \* MERGEFORMAT 4 About Xuezhikang lipid therapy on different time Keywords:] Xuezhikang lipid The main components Xuezhikang hydroxymethyl coenzyme A (HMG-CoA) reductase - lovastatin. I observed Xuezhikang lipid effects and safety. 1 Materials and Methods 1.1 The inclusion criteria All patients were in January 2003 on February -2006 inpatient hospital out-patient and in line with “control of dyslipidemia recommendations” [1]. Selected indicators consistent with the treatment of patients taking the standard and did not have lipid drugs side by side, in addition to liver and kidney disease, thyroid disease, Ⅰ diabetes mellitus, gout drug-induced hypercholesterolemia and familial hypercholesterolemia. 1.2 General Information 58 patients were enrolled, 32 males and 26 females, aged 45 to 70 years, mean age (58.96 + -10.07 years). In which 37 patients with pure hypercholesterolemia, hypertriglyceridemia alone high triacylglycerol in 10 cases, mixed high fat hyperlipidemia in 16 cases. 1.3 Treatment All patients given Xuezhikang (Beijing WBL Peking University Biotech Co, 0.3 g / grain), 1.2 g / d, divided morning and evening 2 times a day orally. Medication before and after taking the details of 1,3,6 months asking about her condition, record drug reactions, blood tests taken forearm blood lipids, glucose, liver function, renal function and cardiac enzymes were measured. 1.4 Statistical Methods Statistical software package using SPSS10.0, all data are expressed by x +-s. 2 Results 2.1 The effect of different time lipid (See Table 1) Table 1 before and after treatment blood at different time (omitted) Note: before treatment, ※ P lt;0.05. Links to download free paper adverse reactions ..com 2.2 Complete a full course of 55 cases observed, lost in 3 cases, 2 cases slightly increased transaminases (69 ~ 87 U / L), did not affect the continued medication, 2 patients had mild abdominal distension, nausea and other gastro